Background: The JCOG0404 randomized controlled trial conducted to compare lap-
| INTRODUC TI ON
At the beginning of this century, several randomized controlled trials for colorectal cancer from all over the world showed excellent short-term results and equal long-term results of laparoscopic surgery compared with open surgery. [1] [2] [3] [4] [5] [6] [7] [8] Most of these trials showed that laparoscopic surgery for colon cancer has been accepted as a standard therapy. In Japan, the Japan Clinical Oncology Group (JCOG) conducted a randomized controlled trial to confirm the efficacy of laparoscopic surgery for stage II or III colon cancer (JCOG0404). [9] [10] [11] The result of JCOG0404 was interpreted to be that laparoscopic surgery could be an acceptable treatment option for stage II or III colon cancer.
In terms of the quality control of this trial, our clinical question was whether the duration of this study could affect the clinical out- . 12 An operative procedure and new surgical devices such as ultrasonic apparatus and a bipolar sealing system for coagulation and incision were incorporated on a nationwide scale and spread during that time. The registration period of this study matched this spread of laparoscopic surgery.
Additionally, improvements made to anticancer agents for patients with recurrent colorectal cancer during the recent 10 years might also influence survival after the occurrence of relapse.
Differences in the treatment results between the phases of a registration period is one of the most important factors in assessing the quality of a therapeutic technique in a clinical study. Registration periods of approximately 4.7 to 7 years have been required in past representative randomized controlled studies. [1] [2] [3] However, evaluation of the results based on different periods within the overall registration period has not been reported in past randomized controlled studies.
Therefore, the purpose of the present study was to evaluate trial outcomes based on different periods within the overall registration period for JCOG0404. We analyzed the changes in short-term and long-term outcomes over time for each registration period and investigated whether quality of the surgical technique was maintained in this trial.
| ME THODS

| Summary of JCOG0404
JCOG0404 was a multi-institutional trial to confirm the non- 
| Measured outcomes
Adequateness of D3 dissection was evaluated by central review.
Cases with distant metastases or severe invasion to adjacent organs were excluded from the photographic analysis. Short-term outcomes of operative time, blood loss, length of postoperative hospital stay, and incidence of early complications were analyzed. Early complications were defined as occurrences within 30 days of surgery.
Terminology and grading of complications were described according to the Common Terminology Criteria for Adverse Events 3.0.
14 Incidence of early complications included all grades in this study.
Long-term outcomes of overall survival and relapse-free survival were compared between three periods within the overall registration period for each approach. Definitions of these outcomes are reported elsewhere. 
| Statistical analysis
All patients were divided into one of three periods to assess the transitional impact of the trial. 
| D3 dissection rates
Forty-four patients were excluded from the evaluation of D3 dissection because of distant metastasis and severe invasion to adjacent organs, as were two patients with problems related to anesthetic management. Photographs were not submitted in 87 patients. Thus, the number of patients with analyzed photographs was 924, resulting in a submission rate of photographs for analysis of 91.4% (924/1011). Conversion rate to open from laparoscopic surgery over time was non-significant, although it was low in the 3rd period (1st period: 5.7%, 2nd period: 7.4%, 3rd period: 2.8%, P = 0.13) (Figure 2 ).
| Short-term outcomes
Incidence of all grades of early complications decreased between the first period and the latter two periods in the open surgery group (1st period: 27.6%, 2nd period: 20.3%, 3rd period: 21.3%, P = 0.31).
However, the incidence was consistently low in all periods in the laparoscopic surgery group (1st period: 14.3%, 2nd period: 14.8%, 3rd period:
13.6%, P = 0.95). There were no significant changes in the incidence of ≥grade 3 early complications over time in either group. In the analysis of the details of complications, there were no significant changes in any diseases in either group. Decreasing tendencies of incisional wound complications (1st period: 13.3%, 2nd period: 9.5%, 3rd period: 8.6%, P = 0.42) and anastomotic leakage (1st period: 6.7%, 2nd period: 1.7%, 3rd period: 4.0%, P = 0.06) were detected in the open surgery group, although they were not significant statistically. (Figure 3 ). A matched-control study reported that operation time for laparoscopic surgery shortened in the latter period. 15 Another study also reported shortened operation time in latter period, regardless of surgical experience or patient factors, as a result of the evolution of surgical apparatus. 16 Therefore, we expected that the tendency for improvement would be especially remarkable in the short-term outcomes of laparoscopic surgery. However, the results of the present study in laparoscopic surgery slightly contradicted our expectation. 
| Long-term outcomes
| D ISCUSS I ON
21-23
Therefore, we expected the overall survival of the patients in the latter two periods to be improved. In fact, the chemotherapy regimens used in this study may not have actually changed. Otherwise, changes of chemotherapy might not have influenced overall survival because there were few deaths in the trial. It was uncertain whether chemotherapy to treat recurrence was changed in this study because data on post-recurrence therapy were not collected. A factor related to the invariable rates of relapse-free survival over time might be the high rate of D3 dissection. Submission of a photograph of the operative field was required in this trial, and this might have caused an increase in the D3 dissection rate that potentially resulted in the excellent long-term prognosis. 24 One important factor influencing both the short-and longterm outcomes was associated with the learning curve for surgical treatment. In the present trial, participation in at least 30 laparoscopic surgeries was required. Although it might be debatable as to whether 30 surgeries is an appropriate number, research into the learning curve in the first half of the 2000s, and also in recent reports, found that laparoscopic procedures stabilized when surgeons had experienced approximately 30 procedures. 25, 26 Certification by the endoscopic surgical skill qualification system introduced by JSES has been required since 2 years after the first patient was registered in this trial (2006). 27 Qualified surgeons were shown to improve the safety of laparoscopic surgery in urology and pediatric surgery. 28, 29 Especially for colorectal surgery, the safety of laparoscopic surgery might be adequately guaranteed under the supervision of a surgeon qualified by JSES. 30 The endoscopic surgical skill qualification system of JSES originated in Japan, and certification is very difficult to obtain. Therefore, we surmised that the quality of laparoscopic surgery was maintained throughout the trial.
In the CLASICC study, the conversion rate improved from 38% in the first year of registration to 16% in the final year. 3 Difference in short-term outcomes according to registration period was reported in a case-matched study. 15 There was some anxiety over how the different registration periods would influence the results because laparoscopic surgery was a new procedure at the beginning of that study. However, there were no differences in short-term and longterm results between the periods in the laparoscopic surgery. The conversion rate of the present study was low at 5.4%, whereas it was reported to range between 10% and 20% in other randomized controlled studies. [1] [2] [3] [4] [5] As the reason, it seems that severe regulation of laparoscopic surgeons influenced the results. In particular, the introduction of JSES-qualified surgeons might have had a very large influence. A qualification system to evaluate technical skill appears to be important in clinical trials relating to surgical procedures.
There are some limitations in the present study. First, we do not have any data on the energy devices used in both arms of the trial.
Therefore, the influence of technological improvements on the outcomes can only be surmised. Second, we do not have data on chemotherapy given for recurrences in each period. In fact, we believe that neither the development of surgical devices nor the improvement of chemotherapy influenced the short-and long-term results during the study period. 
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